NEW YORK (GenomeWeb News) — The European Commission will spend €3 million ($3.8 million) to fund AIDS research studies that will use or develop genomics and proteomics technologies, among others, aimed at developing new HIV/AIDS treatments.
The project, which is funded under the Seventh Framework program, will support studies to develop assays and drug screening technologies, as well as research on early drug candidates with acceptable toxicity profiles.